Clinical trial
Un Approccio di Medicina di Precisione Per Valutare la Perdita di Funzione Proteica e il Potenziale Recupero di CFTR in Fibrosi Cistica e Patologie Correlate / A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
NCT07889973 is registered in ClinicalTrials.gov with Istituto Giannina Gaslini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Un Approccio di Medicina di Precisione Per Valutare la Perdita di Funzione Proteica e il Potenziale Recupero di CFTR in Fibrosi Cistica e Patologie Correlate / A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders
- Lead sponsor
- Istituto Giannina Gaslini
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 165 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis (cf)
Arms
As registered; 4 arms.
-
Patients with cystic fibrosis
Patients with cystic fibrosis
-
children with CFSPID
children with CFSPID
-
patients with idiopathic bronchiectasis
patients with idiopathic bronchiectasis
-
Patients with CFTR-related disorder
Patients with CFTR-related disorder
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Molecular and Functional Characterization
Molecular and Functional Characterization of CFTR Orphan Variants and Their Responsiveness to CFTR Modulator Therapies in Patients with Cystic Fibrosis (CF)
Lead sponsor's other trials
Istituto Giannina Gaslini, most recent start first.
+48 more trials See the organization page
Similar trials
Same condition (Cystic Fibrosis) and phase, most recent start first.
+499 more trials See the condition page